Pre-treatment characteristics and long-term outcomes of recurrent-metastatic head and neck cancer patients treated with immune checkpoint inhibitors

被引:1
作者
Issa, M. [1 ]
Schultz, T. [1 ]
Xu, M. [1 ]
Bhateja, P. [1 ]
Karivedu, V. [1 ]
Dibs, K. [2 ]
Old, M. [3 ]
Kang, S. [3 ]
Gamez, M. [2 ]
Grecula, J. [2 ]
Jhawar, S. [2 ]
Mitchell, D. [2 ]
Seim, N. [3 ]
Agrawal, A. [3 ]
Ozer, E. [3 ]
Baliga, S. S. B. E. [2 ]
Carrau, R. [3 ]
Rocco, J. [3 ]
Blakaj, D. [2 ]
Bonomi, M. [1 ]
机构
[1] Ohio State Univ, Comprehens Canc Ctr James, Med Oncol, Columbus, OH 43210 USA
[2] Ohio State Univ, Comprehens Canc Ctr James, OSUCCC, Radiat Oncol Dept, Columbus, OH 43210 USA
[3] Ohio State Univ, James Canc Hosp, Otolaryngol, Columbus, OH 43210 USA
关键词
D O I
10.1016/j.annonc.2020.08.1063
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
948P
引用
收藏
页码:S674 / S675
页数:2
相关论文
共 50 条
[21]   CHARACTERISTICS, TREATMENT, AND OUTCOMES OF CYTOMEGALOVIRUS INFECTION IN PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS [J].
Panneerselvam, Kavea ;
Szafron, David ;
Amin, Rajan ;
Khurana, Shruti ;
Wei, Dongguang ;
Tan, Dongfeng ;
Okhuysen, Pablo C. ;
Zhang, Hao Chi ;
Thomas, Anusha Shirwaikar ;
Wang, Yinghong .
GASTROENTEROLOGY, 2021, 160 (06) :S51-S52
[22]   THE PROGNOSTIC ROLE OF PRE-TREATMENT GLOBAL LONGITUDINAL STRAIN IN PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS [J].
Ferl, Michal Laufer ;
Tzuberi, Maor ;
Brzezinski, Rafael Y. ;
Flint, Nir ;
Topilsky, Yan ;
Banai, Shmuel ;
Kapusta, Livia .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2025, 85 (12) :2557-2557
[23]   Nutritional needs in patients with recurrent/metastatic Head & Neck Cancer (R/M HNSCC) receiving immune checkpoint inhibitors (ICI) [J].
Brown, Teresa ;
Camilleri, Belinda ;
Bauer, Judy ;
Nottage, Michelle ;
Hughes, Brett G. M. .
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2024, 20 :125-126
[24]   Predictive Value of Skeletal Muscle Mass in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Patients Treated With Immune Checkpoint Inhibitors [J].
Arribas, Lorena ;
Plana, Maria ;
Taberna, Miren ;
Sospedra, Maria ;
Vilarino, Noelia ;
Oliva, Marc ;
Pallares, Natalia ;
Gonzalez Tampan, Ana Regina ;
Miguel Del Rio, Luis ;
Mesia, Ricard ;
Baracos, Vickie .
FRONTIERS IN ONCOLOGY, 2021, 11
[25]   A nomogram based prognostic score to predict overall survival (OS) in recurrent-metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) patients (pts) treated with immune checkpoint inhibitors (ICI) [J].
Mousa, L. ;
Issa, M. ;
Klamer, B. ;
Pan, J. ;
Old, M. ;
Kang, S. ;
Agrawal, A. ;
Ozer, E. ;
Carrau, R. ;
Bhateja, P. ;
Rupert, R. ;
Jhawar, S. ;
Mitchell, D. ;
Gamez, M. ;
Rocco, J. ;
Blakaj, D. ;
Bonomi, M. R. .
ANNALS OF ONCOLOGY, 2019, 30
[26]   Long term outcomes of patients with advanced/unresectable melanoma treated with immune checkpoint inhibitors [J].
Sonke, Eric ;
Angeles, Arkhjamil ;
Nguyen, Thao Phuong ;
Bahl, Gaurav ;
Poon, Vincent Isaac ;
Bernstein, Vanessa ;
Weppler, Alison Margaret ;
Savage, Kerry J. .
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[27]   Long-Term Outcomes of Immune Checkpoint Inhibition in Metastatic Melanoma [J].
Francesca Aroldi ;
Mark R. Middleton .
American Journal of Clinical Dermatology, 2022, 23 :331-338
[28]   Long-Term Outcomes of Immune Checkpoint Inhibition in Metastatic Melanoma [J].
Aroldi, Francesca ;
Middleton, Mark R. .
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2022, 23 (03) :331-338
[29]   The emergence of long-term survivors in recurrent and metastatic squamous cell head and neck cancer [J].
Castet, Florian ;
Brenes, Jesus ;
Taberna, Miren ;
Mesia, Ricard .
CURRENT OPINION IN ONCOLOGY, 2019, 31 (03) :160-168
[30]   Long-term survival outcomes with immune checkpoint inhibitors (ICI) in metastatic uveal melanoma (MUM). [J].
Lee, Cha Len ;
Walsh, Naomi ;
Keane, Fergus ;
Lynch, Emer ;
Reddan, Tadhg ;
Craig, Helen ;
O'Meara, Aileen ;
Smith, Deirdre ;
O'Neill, Valerie ;
Horgan, Noel ;
Kennedy, Susan ;
Gullo, Giuseppe ;
Crown, John .
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)